1 / 6

Cancer Pain Pipeline Therapeutic Assessment Review H1 2015

This report gives extensive data on the remedial improvement for Cancer Pain, complete with similar examination at different stages, therapeutics evaluation by medication target, instrument of activity (MoA), course of organization (RoA) and particle sort, alongside most recent redesigns, and included news and press discharges. It likewise audits key players included in the restorative advancement for Cancer Pain and extraordinary elements on late-stage and suspended undertakings.

jack2222simon
Download Presentation

Cancer Pain Pipeline Therapeutic Assessment Review H1 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cancer Pain - Pipeline Review, H1 2015 By RnRMarketResearch.com Publisher Name : Global Market Direct Date: 24-Jun-2015 No. of pages: 137 Single User License: US $2000 Browse more Reports on Pain Management at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/pain-management . ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  2. Cancer Pain - Pipeline Review, H1 2015 This report gives extensive data on the remedial improvement for Cancer Pain, complete with similar examination at different stages, therapeutics evaluation by medication target, instrument of activity (MoA), course of organization (RoA) and particle sort, alongside most recent redesigns, and included news and press discharges. It likewise audits key players included in the restorative advancement for Cancer Pain and extraordinary elements on late-stage and suspended undertakings. The report improves choice making abilities and help to make viable counter methods to increase upper hand. It fortifies R&D pipelines by distinguishing new targets and MOAs to create first-in-class and best-in-class items. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  3. Cancer Pain - Pipeline Review, H1 2015 Companies Discussed/Mentioned in this Research: Amgen Inc., Amorsa Therapeutics Inc., AngioChem Inc., Aphios Corporation, AstraZeneca Plc, BCN Peptides, S.A., Benitec Biopharma Limited, BioDelivery Sciences International, Inc., ChironWells GmbH, Daiichi Sankyo Company, Limited, Grunenthal GmbH, GW Pharmaceuticals Plc, Immupharma Plc, IntelGenx Corp., Kolon Life Science, Inc., Nektar Therapeutics, Neurocentrx Pharma Ltd., Nippon Kayaku Co., Ltd., Northern Light Pharmaceuticals AB, Orion Oyj, Pain Therapeutics, Inc., Pfizer Inc., Pharmaleads, Recordati S.p.A., Sorrento Therapeutics, Inc., Virobay Inc., Winston Pharmaceuticals, Inc. and Zynerba Pharmaceuticals, Inc. Drugs Profile Discussed in this Research : AMS-410 ER12, ANG-2002, BBI-11008, calpastatin, cebranopadol, crotalphine, DD-04107, dexmedetomidine hydrochloride, dronabinol, Drug for Cancer Neuropathic Pain, fentanyl, fentanyl citrate, fentanyl citrate, fulranumab, HS-198, hydromorphone hydrochloride, INT-0028, IPP-102199, ketamine hydrochloride ER, KLS-2010, methadone hydrochloride, nabiximols, Nervarna, NKTR-192, Peptide to Block Voltage-Dependent N-Type Calcium Channel for Cancer Pain and Fibromyalgia, PGN-202, PL-265, Q-201, QX-314, resiniferatoxin, saracatinibdifumarate, Small Molecule 1 to Block Sodium Channels for Cancer Pain and Epilepsy, Small Molecule to Antagonize Chemokine Receptor for Cancer Pain, tanezumab, VBY-825, zucapsaicin and ZYN-001 ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  4. Cancer Pain - Pipeline Review, H1 2015 Scope For Cancer Pain - Pipeline Review, H1 2015 • The report provides a snapshot of the global therapeutic landscape of Cancer Pain • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities • The report reviews key players involved in the therapeutics development for Cancer Pain and enlists all their major and minor projects • The report summarizes all the dormant and discontinued pipeline projects • A review of the Cancer Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages • A detailed assessment of monotherapy and combination therapy pipeline projects ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  5. Cancer Pain - Pipeline Review, H1 2015 Reasons to Buy: • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • Develop strategic initiatives by understanding the focus areas of leading companies • Identify and understand important and diverse types of therapeutics under development for Cancer Pain • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline • Devise corrective measures for pipeline projects by understanding Cancer Pain pipeline depth and focus of Indication therapeutics ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  6. Cancer Pain - Pipeline Review, H1 2015 For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research  publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

More Related